Atopica® (cyclosporine capsules) USP MODIFIED for dogs

Atopic dermatitis is a complex condition, and each case has its own symptoms that vary in severity. Atopica is the only treatment that offers 20 years of proven long-term, well-tolerated, flexible relief.1,2

Why choose Atopica?

Atopica provides long-term, well-tolerated relief from atopic dermatitis with a broad mode of action that targets the source of inflammation.1,2

  • Dog Icon

    Proven to relieve itch and reduce skin lesions in dogs³,

  •  Calendar Icon

    Long-term relief with lasting results³,

  • Two pill capsules leaning on one other

    Flexible, tapered dosing helps lower costs for dog owners over time

 Atopica Dosing and Administration Table


Dog body weight (lbs) - 4–6.5 lbs
Dog body weight (kg) -

2–2.9 kg

Dose 5 mg/kg -

10 mg capsule

Dog body weight (lbs) - 6.6–9 lbs
Dog body weight (kg) -

3–3.9 kg

Dose 5 mg/kg -

2 x 10 mg capsules

Dog body weight (lbs) - 9.1–16 lbs
Dog body weight (kg) -

4–7.9 kg

Dose 5 mg/kg -

25 mg capsule

Dog body weight (lbs) - 16.1–33 lbs
Dog body weight (kg) -

8–14.9 kg

Dose 5 mg/kg -

50 mg capsule

Dog body weight (lbs) - 33.1–64 lbs
Dog body weight (kg) -

15–28.9 kg

Dose 5 mg/kg -

100 mg capsule

Dog body weight (lbs) - 64.1–79 lbs
Dog body weight (kg) -

29–35.9 kg

Dose 5 mg/kg -

100 mg capsule +50 mg capsule

Dog body weight (lbs) - 79.1–121 lbs
Dog body weight (kg) -

36–55.9 kg

Dose 5 mg/kg -

2 x 100 mg capsules

Treat atopic dermatitis beyond the itch with Atopica

Contact your Elanco sales representative for more information.

Atopica® is indicated for the control of atopic dermatitis in dogs weighing at least 4 pounds and at least 6 months of age.

Important Safety Information

Do not use Atopica® in dogs with a history of neoplasia, with a hypersensitivity to cyclosporine, or in reproducing dogs. Atopica is a systemic immunosuppressant that may increase susceptibility to infection and the development of neoplasia. For use only in dogs. Capsules should not be broken or opened. Wear gloves during administration and wash hands after administration. Gastrointestinal problems and gingival hyperplasia may occur at the initial dose. For full prescribing information, see package label.